JP2016527215A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527215A5
JP2016527215A5 JP2016524705A JP2016524705A JP2016527215A5 JP 2016527215 A5 JP2016527215 A5 JP 2016527215A5 JP 2016524705 A JP2016524705 A JP 2016524705A JP 2016524705 A JP2016524705 A JP 2016524705A JP 2016527215 A5 JP2016527215 A5 JP 2016527215A5
Authority
JP
Japan
Prior art keywords
group
alkyl
formula
optionally substituted
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016524705A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016527215A (ja
JP6730183B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/001925 external-priority patent/WO2015003816A2/en
Publication of JP2016527215A publication Critical patent/JP2016527215A/ja
Publication of JP2016527215A5 publication Critical patent/JP2016527215A5/ja
Application granted granted Critical
Publication of JP6730183B2 publication Critical patent/JP6730183B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016524705A 2013-07-12 2014-07-14 シストバクトアミド(Cystobactamides) Active JP6730183B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13003539.7 2013-07-12
EP13003539 2013-07-12
PCT/EP2014/001925 WO2015003816A2 (en) 2013-07-12 2014-07-14 Cystobactamides

Publications (3)

Publication Number Publication Date
JP2016527215A JP2016527215A (ja) 2016-09-08
JP2016527215A5 true JP2016527215A5 (US07794700-20100914-C00152.png) 2017-08-03
JP6730183B2 JP6730183B2 (ja) 2020-07-29

Family

ID=48792948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016524705A Active JP6730183B2 (ja) 2013-07-12 2014-07-14 シストバクトアミド(Cystobactamides)

Country Status (7)

Country Link
US (3) US20160145304A1 (US07794700-20100914-C00152.png)
EP (1) EP3019615B1 (US07794700-20100914-C00152.png)
JP (1) JP6730183B2 (US07794700-20100914-C00152.png)
CN (1) CN105793424B (US07794700-20100914-C00152.png)
AU (1) AU2014289663B2 (US07794700-20100914-C00152.png)
CA (1) CA2917767C (US07794700-20100914-C00152.png)
WO (1) WO2015003816A2 (US07794700-20100914-C00152.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160145304A1 (en) 2013-07-12 2016-05-26 Helmholtz-Zentrum für Infektionsforschung GmbH Cystobactamides
GB201402277D0 (en) 2014-02-10 2014-03-26 Sentinel Oncology Ltd Pharmaceutical compounds
KR101747702B1 (ko) 2014-05-15 2017-06-19 한국생명공학연구원 신규한 항균성 화합물 및 이의 용도
US10519099B2 (en) 2014-11-26 2019-12-31 Helmholtz-Zentrum für Infektionsforschung GmbH Cystobactamides
CN105712894A (zh) * 2016-03-23 2016-06-29 叶芳 一种3-甲氧基-4-氨基苯甲酸及其制备方法
JP7037122B2 (ja) * 2016-09-28 2022-03-16 日産化学株式会社 ジアミンおよびその利用
JOP20200001A1 (ar) 2017-07-11 2022-10-30 Vertex Pharma كاربوكسأميدات بوصفها معدلات لقنوات الصوديوم
EP3655394B1 (en) 2017-07-18 2023-11-22 Technische Universität Berlin Novel albicidin derivatives, their use and synthesis
AU2018321152B2 (en) * 2017-08-23 2023-07-06 Helmholtz-Zentrum für Infektionsforschung GmbH Novel cystobactamide derivatives
BR112020003725A2 (pt) 2017-10-06 2020-11-03 Forma Therapeutics, Inc. inibição da peptidase 30 específica de ubiquitina
AU2019207608B2 (en) 2018-01-10 2024-03-28 Recurium Ip Holdings, Llc Benzamide compounds
AU2019222644B2 (en) 2018-02-13 2021-04-01 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
CN112041311B (zh) 2018-04-19 2023-10-03 吉利德科学公司 Pd-1/pd-l1抑制剂
JP7449242B2 (ja) 2018-05-17 2024-03-13 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的ペプチダーゼ30(usp30)阻害剤として有用な縮合二環化合物
EP4234030A3 (en) 2018-07-13 2023-10-18 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
SI3860989T1 (sl) 2018-10-05 2023-06-30 Forma Therapeutics, Inc. Kondenzirani pirolini,ki delujejo kot zaviralci ubikvitin-specifične proteaze (usp30)
WO2020086556A1 (en) 2018-10-24 2020-04-30 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
CA3145864A1 (en) 2019-07-03 2021-01-07 Sumitomo Dainippon Pharma Oncology, Inc. Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof
TW202128675A (zh) 2019-12-06 2021-08-01 美商維泰克斯製藥公司 作為鈉通道調節劑之經取代四氫呋喃
PE20241335A1 (es) 2021-06-04 2024-07-03 Vertex Pharma N-(hidroxialquil (hetero)aril) tetrahidrofurano carboxamidas como moduladores de canales de sodio
CN113563220B (zh) * 2021-06-25 2023-08-29 华中农业大学 一种抗菌化合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525354A (en) * 1983-09-14 1985-06-25 University Of Hawaii Antibiotic and process for the production thereof
US7020622B1 (en) * 1997-06-10 2006-03-28 Linkshare Corporation Transaction tracking, managing, assessment, and auditing data processing system and network
FR2772025B1 (fr) 1997-12-10 2000-03-03 Guerbet Sa Chelates metalliques de macrocycles polyaminocarboxyliques et leur application a l'imagerie par resonance magnetique
MXPA02010565A (es) * 2000-04-28 2004-05-17 Kosan Biosciences Inc Produccion de policetidos.
CA2413702A1 (en) 2000-06-28 2002-01-03 Teva Pharmaceuticals Industries Ltd. Carvedilol
AU2003286498A1 (en) * 2002-10-18 2004-05-04 Centre De Cooperation Internationale En Recherche Agronomique Pour Le Developpement (Cirad) Complete biosynthetic gene set for biosynthesis of albicidin, resistance genes, and uses thereof
WO2006109846A1 (ja) 2005-04-06 2006-10-19 Takeda Pharmaceutical Company Limited トリアゾール誘導体およびその用途
US7758972B2 (en) * 2006-09-26 2010-07-20 Semiconductor Energy Laboratory Co., Ltd. Stilbene derivative, light emitting element, light emitting device, and electronic appliance
JP5379965B2 (ja) * 2006-09-26 2013-12-25 株式会社半導体エネルギー研究所 スチルベン誘導体、発光素子および発光装置
US8236983B2 (en) * 2008-03-13 2012-08-07 Board Of Regents, The University Of Texas System Composition and method for the treatment of diseases affected by apoptosis
US8618324B2 (en) * 2007-03-13 2013-12-31 Board Of Regents, The University Of Texas System Composition and method for making oligo-benzamide compounds
WO2013078277A1 (en) * 2011-11-23 2013-05-30 The Board Of Regents Of The University Of Texas System Oligo-benzamide compounds and their use in treating cancers
EP2956437B1 (en) * 2013-02-15 2023-05-10 Technische Universität Berlin Albicidin derivatives for the treatment of bacterial infections
US20160145304A1 (en) * 2013-07-12 2016-05-26 Helmholtz-Zentrum für Infektionsforschung GmbH Cystobactamides
KR101747702B1 (ko) 2014-05-15 2017-06-19 한국생명공학연구원 신규한 항균성 화합물 및 이의 용도
US10519099B2 (en) * 2014-11-26 2019-12-31 Helmholtz-Zentrum für Infektionsforschung GmbH Cystobactamides

Similar Documents

Publication Publication Date Title
JP2016527215A5 (US07794700-20100914-C00152.png)
AU2022241543B2 (en) 1,2,4-oxadiazole derivatives as immunomodulators
JP2019514426A5 (US07794700-20100914-C00152.png)
RU2017105486A (ru) Фармацевтическая композиция для лечения злокачественной опухоли, положительной по мутации flt3, ингибитор мутантного flt3 и их применение
JP6523337B2 (ja) RORγのアゴニストとしての使用及び疾患治療のためのベンゼンスルホンアミド及び関連化合物
WO2014176636A9 (en) Compounds and methods of treating infections
RU2014145819A (ru) Бициклическое соединение
MX348360B (es) Anticuerpo biespecifico psmaxcd3 de simple cadena especifico de especies cruzadas.
US20060287306A1 (en) Compounds to treat alzheimer's disease
EA201490709A1 (ru) Адъювантное соединение
JP2013511553A5 (US07794700-20100914-C00152.png)
JP2020500916A5 (US07794700-20100914-C00152.png)
RU2013140169A (ru) Противоопухолевое терапевтическое средство
WO2010007316A3 (fr) NOUVEAUX DERIVES TRIAZOLO(4,3-a)PYRIDINE,LEUR PROCEDE DE PREPARATION,LEUR APPLICATION A TITRE DE MEDICAMENTS,COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE MET
JP2018507204A5 (US07794700-20100914-C00152.png)
JP2015107945A5 (US07794700-20100914-C00152.png)
JP2017530192A5 (US07794700-20100914-C00152.png)
JP2020514299A5 (US07794700-20100914-C00152.png)
JP2019535669A5 (US07794700-20100914-C00152.png)
JP2017519796A5 (US07794700-20100914-C00152.png)
JP2013515037A5 (US07794700-20100914-C00152.png)
JP2015510493A5 (US07794700-20100914-C00152.png)
JP2018536645A5 (US07794700-20100914-C00152.png)
JP2012513982A5 (US07794700-20100914-C00152.png)
JP2014517037A5 (US07794700-20100914-C00152.png)